Journal of Oncology Research Review & Reports最新文献_第3页

Target Oncogenic Receptors in Tumours, A Hot Topics Today 肿瘤中的靶向致癌受体，当今的热门话题

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)116

G. Zhu

引用次数: 0

Criteria for the Optimal Extent of Lymph Node Dissection for Gastric Carcinoma: Number of Harvested Lymph Nodes or Properly Dissected Relevant Lymph Node Stations? Standard or Personalized Extent? 胃癌最佳淋巴结清扫程度的标准:切除淋巴结的数量还是适当清扫的相关淋巴结站?标准程度还是个性化程度?

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)119

R. Bayramov

引用次数: 0

Radiosurgery with Gamma Knife in Central Neurocitoma: Case Report 伽玛刀放射治疗中枢神经瘤1例

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)120

Roxana Risco Neyra, P. F. Rivera

引用次数: 0

Multiple Solitary Plasmacytoma: A Rare Presentation 多发孤立浆细胞瘤:一种罕见的表现

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)124

A. Kuchkuntla, N. Nandu

引用次数: 1

A Review on the Neuroendocrine Regulation of the Endothelial Cells 内皮细胞神经内分泌调节研究进展

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)115

P. Lissoni, F. Rovelli

引用次数: 0

Prediction of Breast Cancer Risk Factors Using Neural Network Analytics: an Empirical Study 用神经网络分析预测乳腺癌危险因素的实证研究

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)118

Ahed J. Alkhatib, Shadi M. Alkhatib

{"title":"Prediction of Breast Cancer Risk Factors Using Neural Network Analytics: an Empirical Study","authors":"Ahed J. Alkhatib, Shadi M. Alkhatib","doi":"10.47363/jonrr/2021(2)118","DOIUrl":"https://doi.org/10.47363/jonrr/2021(2)118","url":null,"abstract":"Breast cancer is the most prevalent cancer affecting women. Identifying breast cancer risk factors are crucially to be established. The main objectives of the present study were to identify the predictors of breast cancer risk factors and their relative importance using neural network analysis. The present study depended on neural network analysis of data posted on [1]. The dataset is about predictors of breast cancer. There were 9 covariates included and one dependent variable, output (no disease (1), or disease (2)). The dataset was composed of 116 cases. The category of no disease comprised 79 (68.1%) cases, whereas the disease category included 37 cases (31.9%). Architecture model was built with some characteristics such as training part: gross entropy error was 23.7884, the percent of incorrect predictions was 10.1%. Stopping rule used was 1 consecutive step(s) with no decrease in error. For testing part, gross entropy error was 14,327, the percent of incorrect predictions was 13.5%. The relative importance of breast cancer was in the following order: glucose, resistin, BMI, age, leptin, adiponectin, MCP-1, insulin, and HOMA. Taken together, neural network analysis is an efficient tool to predict breast cancer risk factors.","PeriodicalId":351114,"journal":{"name":"Journal of Oncology Research Review & Reports","volume":"54 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"127769007","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

To Assess the Knowledge and Awareness about Breast, Cervical and Oral Cancer Screening Among Oncology Nurses in Tertiary Cancer Centre 评估三级癌症中心肿瘤科护士对乳癌、子宫颈癌及口腔癌筛检的知识及意识

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)125

Jyoti P. Patel, Sindhu Shibu Nair

{"title":"To Assess the Knowledge and Awareness about Breast, Cervical and Oral Cancer Screening Among Oncology Nurses in Tertiary Cancer Centre","authors":"Jyoti P. Patel, Sindhu Shibu Nair","doi":"10.47363/jonrr/2021(2)125","DOIUrl":"https://doi.org/10.47363/jonrr/2021(2)125","url":null,"abstract":"Background: To better primary health care and better-trained nurses, knowing the causes of cancer provides a basis for understanding the potential for prevention or early detection of the disease. Our study aimed to assess knowledge and awareness about breast, cervical and oral cancer screening amongst oncology nurses at a tertiary cancer centre. Methodology: An anonymised questionnaire based study was conducted amongst nurses at a tertiary cancer centre. We used NCG e-leaning questionnaire to assess knowledge (which includes breast, oral and cervical knowledge and awareness related questionnaire). Results: A total of 313 participants fulfilled the inclusion criteria and were enrolled in this study. Age range of participants was from 21 to 54 years (mean = 29.8; SD = 8.14). Knowledge and awareness about breast cancer were significantly associated gender (p=0.014) and marital status (p=0.00). Although, Knowledge and awareness about cervical cancer were significantly associated with gender (p=0.002) and years of experience (p=0.03). The age (p=0.001), marital status (p=0.002) and years of experience (p=<0.001) was statistically significantly associated with knowledge and awareness about oral cancer. Conclusion: Our data suggest that levels of knowledge and understanding of cervical cancer as well as its preventable nature should be improved. Continuing nurse education may contribute to strengthen cervical cancer screening programs. Nursing staff, if properly aware of this disease, can educate the masses and hence increase health-seeking behaviour in women.","PeriodicalId":351114,"journal":{"name":"Journal of Oncology Research Review & Reports","volume":"18 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-31","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"123941985","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 0

Pet-Ct Based Radiotherapy Planning 基于Pet-Ct的放疗计划

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)121

A. Kuchkuntla, Aarathi Reddy

引用次数: 0

Citiscreen Project for Cancer Screening: Colorectal, Prostate, Bladder, Testicular, Thyroid and Skin Cancers Citiscreen癌症筛查项目:结直肠癌、前列腺癌、膀胱癌、睾丸癌、甲状腺癌和皮肤癌

Journal of Oncology Research Review & Reports Pub Date : 2020-12-31 DOI: 10.47363/jonrr/2021(2)117

B. Petrikovsky

引用次数: 0

COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know? 癌症患者需要接种COVID-19疫苗，肿瘤学家和癌症患者需要知道什么?

Journal of Oncology Research Review & Reports Pub Date : 2020-12-30 DOI: 10.47363/JONRR/2020(1)114

H. Al-Shamsi, Mona A. Alfares, S. Alrawi

{"title":"COVID-19 Vaccination for Cancer Patients, What Oncologists and Cancer Patients Need to Know?","authors":"H. Al-Shamsi, Mona A. Alfares, S. Alrawi","doi":"10.47363/JONRR/2020(1)114","DOIUrl":"https://doi.org/10.47363/JONRR/2020(1)114","url":null,"abstract":"As the current evidence is accumulating in support of multiple COVID-19 vaccine in general population while the final regulatory approvals are still pending, multiple vaccine candidates have already received temporary authorization for emergency use. The mRNA vaccines are new to the clinical practice and global regulators must balance the lack of medium to longer-term data on these novel mRNA COVID-19 vaccines.The inactivated vaccines have been used in cancer patients in the past with excellent safety profile and they may be theoretically the safest vaccine for cancer patients. Currently there are no formal COVID-19 vaccine trial designed specifically for cancer patients. Some of the current major trials excluded cancer patients while others did not explicitly excluded malignancies. Early reports indicate that some cancer patients were able to enroll in some of the vaccine trials, yet no clear information if these patients were on active systemic therapies or surveillance. There is a need for a dedicated COVID-19 vaccine trials for cancer patients. The UK Independent report by the “ Joint Committee on Vaccination and Immunisation for the Priority groups for coronavirus (COVID-19) vaccination” recommended “bone marrow and stem cell transplant recipients and people with specific cancers” to receive priority vaccination, without further clarification which “specific cancers” were referred to. Until further data are available, recommendations for vaccination for COVID-19 for cancer patients cannot be routinely recommended. At the current time evaluation of cancer patients who wish to consider COVID-19 vaccination should be done in the context of clinical trials, if there is no access to clinical trials; This should be addressed “case by case” basis with clear discussion about potential benefits, risks and uncertainties surrounding COVID-19 vaccination for cancer patients at the current time.","PeriodicalId":351114,"journal":{"name":"Journal of Oncology Research Review & Reports","volume":"80 1","pages":"0"},"PeriodicalIF":0.0,"publicationDate":"2020-12-30","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"114262426","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}

引用次数: 1